⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer

Official Title: Phase II Randomized Study of Two Different Schedules of Docetaxel or Paclitaxel for Metastatic Breast Cancer

Study ID: NCT00006120

Conditions

Breast Cancer

Interventions

docetaxel
paclitaxel

Study Description

Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase II trial to compare the effectiveness of two different regimens of docetaxel or paclitaxel in treating women who have unresectable locally advanced or metastatic breast cancer.

Detailed Description: OBJECTIVES: * Compare the response rate, progression free survival, and overall survival in women with unresectable locally advanced or metastatic breast cancer treated with two different schedules of docetaxel or paclitaxel. * Compare the toxicities and pharmacoeconomics of these four regimens in these patients. * Compare the quality of life of patients treated with these four regimens. OUTLINE: This is a randomized, multicenter study. Patients are stratified by center, age, ECOG performance status, hormone receptor status (positive vs negative), metastasis to liver (yes vs no), and presence of disease progression following anthracyclines (yes vs no). Patients are randomized to one of four treatment arms. * Arm I: Patients receive docetaxel IV over 1 hour on day 1. * Arm II: Patients receive paclitaxel IV over 3 hours on day 1. * Arm III: Patients receive docetaxel IV over 1 hour on days 1, 8, 15, 22, 29, and 36. * Arm IV: Patients receive paclitaxel IV over 1 hour on days 1, 8, 15, 22, 29, and 36. Courses repeat every 3 weeks (arms I and II) or every 8 weeks (arms III and IV) in the absence of disease progression or unacceptable toxicity. Quality of life is assessed prior to treatment and then every 8 weeks. PROJECTED ACCRUAL: A total of 165 patients will be accrued for this study.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Centre Hospitalier d'Antibes, Antibes, , France

Centre Hospitalier Victor Dupouy, Argenteuil, , France

Institut Sainte Catherine, Avignon, , France

Clinique Floreal, Bagnolet, , France

Centre D'Oncologie Du Pays-Basque, Bayonne, , France

C.H.G. Beauvais, Beauvais, , France

Hopital Fontenoy, Chartres, , France

Centre Jean Perrin, Clermont-Ferrand, , France

Hopital Louis Mourier, Colombes, , France

Centre Hospitalier Laennec, Creil, , France

Hopital Intercommunal De Creteil, Creteil, , France

Hopital Drevon, Dijon, , France

Polyclinique Jeanne d'Arc - service de Radiotherapie Oncologie, Gien, , France

Centre Jean Bernard, Le Mans, , France

Hopital Desgenettes - Service de Medecine Interne, Lyon, , France

Centre de Radiotherapie et Oncologie Saint-Faron, Mareuil Les Meaux, , France

Hopital Saint Joseph, Marseille, , France

Hopital Notre-Dame de Bon Secours, Metz, , France

CH Meulan, Meulan, , France

Intercommunal Hospital, Montfermeil, , France

Centre Hospitalier de Mulhouse, Mulhouse, , France

Clinique Hartmann, Neuilly sur Seine, , France

American Hospital of Paris, Neuilly Sur Seine, , France

Clinique Geoffroy St. Hillaire, Paris, , France

Hotel Dieu de Paris, Paris, , France

Hopital Saint Antoine, Paris, , France

Hopital Tenon, Paris, , France

Clinique Ste - Marie, Pontoise, , France

Polyclinique De Courlancy, Reims, , France

Centre du Rouget, Sarcelles, , France

C.H. Senlis, Senlis, , France

Clinique de l'Orangerie, Strasbourg, , France

Clinique Pasteur, Toulouse, , France

Clinique Fleming, Tours, , France

Hopital de la Ville D'Esch-sur-Alzette, Esch-sur-Alzette, , Luxembourg

Contact Details

Name: Joseph Gligorov, MD

Affiliation: Hopital Tenon

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: